| Expression pattern: |
UP |
| Associated gene: |
- |
| Associated microRNA: |
miR-215 |
| Biological function: |
hsa_circ_0003528 promotes aggressive cellular behaviors in TNBC, including proliferation, migration, and invasion; its knockdown suppresses these behaviors. |
| Molecular mechanism: |
hsa_circ_0003528 may sponge or bind miR-215 and facilitate TNBC tumorigenesis by regulating miR-215 expression. |
| Biological pathway or process: |
ceRNA regulation (promotes); proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes) |
| Detected method: |
Q
M
|
| Validation methods: |
Microarray; RT-qPCR; Clinical Sample Validation; Cohort Study; Survival Analysis; Bioinformatics Analysis; Luciferase Reporter Assay; Transfection; CCK8; Transwell Assay |
| Clinical significance: |
High hsa_circ_0003528 expression was associated with tumor size, clinical stage, grade, lymph node metastasis, shorter overall survival, and may serve as a prognostic predictor for TNBC patients. |
| Description: |
hsa_circ_0003528/circSEC24A is upregulated in breast cancer, particularly TNBC, and high expression is associated with adverse clinicopathological features and poor overall survival. Functionally, hsa_circ_0003528 promotes TNBC cell proliferation, migration, and invasion, at least partly by binding/regulating miR-215. The study suggests hsa_circ_0003528 as a prognostic biomarker and potential therapeutic target for TNBC. |
| Confidence score: |
0.7513 |